Drug profile · INN
venlafaxine hydrochloride
EFFEXOR
venlafaxine hydrochloride (EFFEXOR) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — venlafaxine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
venlafaxine hydrochloride (EFFEXOR) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Sodium-dependent noradrenaline transporter
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is venlafaxine hydrochloride?
venlafaxine hydrochloride (EFFEXOR) is a norepinephrine transporter inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for venlafaxine hydrochloride?
EFFEXOR is a marketed brand name for venlafaxine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of venlafaxine hydrochloride?
venlafaxine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.